Discontinued — last reported Q2 '24
GE HealthCare Technologies Ultrasound — EBIT decreased by 2.2% to $178.00M in Q2 2024 compared to the prior quarter. Year-over-year, this metric declined by 6.8%, from $191.00M to $178.00M. Over 2 years (FY 2021 to FY 2023), Ultrasound — EBIT shows relatively stable performance with a -3.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher EBIT margins suggest strong operational efficiency and pricing power, whereas declining EBIT may indicate rising input costs or increased competitive discounting.
Earnings Before Interest and Taxes (EBIT) for the ultrasound segment measures the operational profitability of the busin...
Standardized across the medical device industry as a measure of segment-level operating performance.
gehc_segment_ultrasound_ebit| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $221.25M | $221.25M | $221.25M | $192.00M | $220.00M | $211.00M | $285.00M | $207.00M | $191.00M | $179.00M | $244.00M | $182.00M | $178.00M |
| QoQ Change | — | +0.0% | +0.0% | -13.2% | +14.6% | -4.1% | +35.1% | -27.4% | -7.7% | -6.3% | +36.3% | -25.4% | -2.2% |
| YoY Change | — | — | — | — | -0.6% | -4.6% | +28.8% | +7.8% | -13.2% | -15.2% | -14.4% | -12.1% | -6.8% |